BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25102319)

  • 1. Inhaled bronchodilator use for infants with bronchopulmonary dysplasia.
    Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
    J Perinatol; 2015 Jan; 35(1):61-6. PubMed ID: 25102319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled bronchodilator exposure in the management of bronchopulmonary dysplasia in hospitalized infants.
    Euteneuer JC; Kerns E; Leiting C; McCulloh RJ; Peeples ES
    J Perinatol; 2021 Jan; 41(1):53-61. PubMed ID: 32759956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia.
    Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
    PLoS One; 2014; 9(9):e106838. PubMed ID: 25192252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled Corticosteroid Exposure in Hospitalized Infants with Bronchopulmonary Dysplasia.
    Leiting C; Kerns E; Euteneuer JC; McCulloh RJ; Peeples ES
    Am J Perinatol; 2024 May; 41(S 01):e85-e93. PubMed ID: 35523409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia.
    Slaughter JL; Stenger MR; Reagan PB
    Pediatrics; 2013 Apr; 131(4):716-23. PubMed ID: 23478874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and efficacy of two doses of aerosolized albuterol in ventilated infants with BPD: A randomized controlled crossover trial.
    Napolitano N; Dysart K; Soorikian L; Zhang H; Panitch H; Jensen E
    Pediatr Pulmonol; 2021 Jan; 56(1):97-104. PubMed ID: 33095509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia.
    Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B
    J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia.
    Pantalitschka T; Poets CF
    Pediatr Pulmonol; 2006 Aug; 41(8):703-8. PubMed ID: 16779858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hood versus mask nebulization in infants with evolving bronchopulmonary dysplasia in the neonatal intensive care unit.
    Kugelman A; Amirav I; Mor F; Riskin A; Bader D
    J Perinatol; 2006 Jan; 26(1):31-6. PubMed ID: 16341026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating endothelial progenitor cells decrease in infants with bronchopulmonary dysplasia and increase after inhaled nitric oxide.
    Qi Y; Jiang Q; Chen C; Cao Y; Qian L
    PLoS One; 2013; 8(11):e79060. PubMed ID: 24244420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled salbutamol and beclomethasone for preventing broncho-pulmonary dysplasia: a randomised double-blind study.
    Denjean A; Paris-Llado J; Zupan V; Debillon T; Kieffer F; Magny JF; Desfrères L; Llanas B; Guimaraes H; Moriette G; Voyer M; Dehan M; Breart G
    Eur J Pediatr; 1998 Nov; 157(11):926-31. PubMed ID: 9835439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions.
    Clouse BJ; Jadcherla SR; Slaughter JL
    PLoS One; 2016; 11(2):e0148188. PubMed ID: 26840339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia.
    Banks BA; Seri I; Ischiropoulos H; Merrill J; Rychik J; Ballard RA
    Pediatrics; 1999 Mar; 103(3):610-8. PubMed ID: 10049965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicose bronchiectasis and bronchopulmonary dysplasia.
    Hayes D; Kriss VM; Iocono JA; Dixon BJ; Collins PB; Ballard HO
    Respir Care; 2009 Nov; 54(11):1493-5. PubMed ID: 19863834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease.
    Wilkie RA; Bryan MH
    J Pediatr; 1987 Aug; 111(2):278-82. PubMed ID: 2956405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to bronchodilators in clinically stable 1-year-old patients with bronchopulmonary dysplasia.
    De Boeck K; Smith J; Van Lierde S; Devlieger H
    Eur J Pediatr; 1998 Jan; 157(1):75-9. PubMed ID: 9461369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of inhaled nitric oxide on pulmonary and cardiac function in preterm infants with evolving bronchopulmonary dysplasia.
    Athavale K; Claure N; D'Ugard C; Everett R; Swaminathan S; Bancalari E
    J Perinatol; 2004 Dec; 24(12):769-74. PubMed ID: 15496967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.